Is commercializing gene therapy manufacturing an unsolvable problem? We ask an expert on the frontlines.

Medicare publishes policy for amyloid mAbs and Alzheimer’s disease. It’s not good news for Aduhelm.

Get excited, because the results are in! Find out who won the 2022 Innovation Awards

African vaccine production needs a boost. Here’s how Aspen is working to make that happen.

We sat down to talk shop with Novo Nordisk Executive Vice President Ludovic Helfgott

One decade behind the EU, biosimilars are arriving in the US. What can we expect? Jeff Baldetti from Cardinal Health has a few ideas.

How an initiative from EFPIA and a new public database on chemical substances could reduce animal experiments.

Driven by the success of COVID-19 vaccines, mRNA products are expanding drug developers’ pipelines.

Overcoming supply chain woes will require digital intervention.

How bioelectronic assays helped demonstrate the value of 3D iPSC cultures in modeling human brain development.